CSF amyloid â38 as a novel diagnostic marker for dementia with Lewy bodies

[Guest guest]

CSF amyloid â38 as a novel diagnostic marker for dementia with Lewy bodies

Conclusion This study suggests that the level of Aâ38 can potentially contribute

in the diagnostic distinction between AD and DLB when combined with Aâ42. Single

measures had low diagnostic accuracy, suggesting that developing a panel of

markers is the most promising strategy. Studies with independent and larger

samples and a priori cut-offs are needed to test this hypothesis.

http://tinyurl.com/34fctkx